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Implications of iron deficiency/anemia on the classification of
diabetes using HbA1c
SM Attard1, AH Herring2,3, H Wang4, A-G Howard2,3, AL Thompson2,5, LS Adair1,2, EJ Mayer-Davis1,6 and P Gordon-Larsen1,2
BACKGROUND/OBJECTIVES: Nonglycemic factors like iron deficiency (ID) or anemia may interfere with classification of diabetes
and prediabetes using hemoglobin A1c (HbA1c). However, few population-based studies of diabetes in areas with endemic
ID/anemia have been conducted. We aimed to determine how mutually exclusive categories of ID alone, anemia alone and
iron-deficiency anemia (IDA) were each associated with prediabetes and diabetes prevalence using fasting blood glucose (FBG)
versus HbA1c in a population-based study of adults with endemic ID/anemia.
SUBJECTS/METHODS: We used data from the China Health and Nutrition Survey, a longitudinal, population-based study across
228 communities within nine provinces of China. This analysis included 7308 adults seen in the 2009 survey aged 18–75 years. We
used descriptive and covariate-adjusted models to examine relative risk of prediabetes and diabetes using FBG alone, HbA1c alone,
HbA1c and FBG, or neither (normoglycemia) by anemia alone, ID alone, IDA or normal iron/hemoglobin.
RESULTS: Approximately 65% of individuals with diabetes in our sample were concordantly classified with diabetes using both FBG
and HbA1c, while 35% had a discordant diabetes classification: they were classified using either FBG or HbA1c, but not both. Fewer
participants with ID alone versus normal iron/hemoglobin were classified with diabetes using HbA1c only. From covariate-adjusted,
multinomial regression analyses, the adjusted prevalence of prediabetes using HbA1c only was 22% for men with anemia alone,
but 13% for men with normal iron/hemoglobin. In contrast, the predicted prevalence of prediabetes using HbA1c only was 8% for
women with ID alone, compared with 13% for women with normal iron/hemoglobin.
CONCLUSIONS: These findings suggest potential misclassification of diabetes using HbA1c in areas of endemic ID/anemia.
Estimating diabetes prevalence using HbA1c may result in under-diagnosis in women with ID and over-diagnosis in men with
anemia.
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INTRODUCTION
Fasting blood glucose (FBG) and hemoglobin A1c (HbA1c) are
important diagnostic measures to assess glycemia; however,
HbA1c is increasingly recommended for use in population-based
settings because it does not require fasting and has low intra-
individual variability.1 In the general population, HbA1c and FBG
do not classify diabetes identically because they reflect glycemia
status over different time periods.2,3 It is well established that
HbA1c levels can be affected by conditions unrelated to diabetes
including anemia, blood loss and iron deficiency (ID).1 Anemia
affects an estimated five million women of reproductive age in the
US4 and 1.6 billion individuals worldwide,4 a substantial portion of
whom have concurrent ID.5 Thus, there is potential for diabetes
misclassification across many populations worldwide. To under-
stand the clinical implications of ID and/or anemia for diabetes
prevalence estimates when using HbA1c, population-based
research in areas with a high prevalence of ID and/or anemia is
needed.
The magnitude and direction of diabetes misclassification due
to ID and anemia is not well understood. The mechanism through
which ID and anemia influences HbA1c has yet to be fully
elucidated;5–8 however, most epidemiologic studies suggest that
iron-deficiency anemia (IDA) can result in spuriously high HbA1c
values,6,7,9,10 though some suggest there is lower HbA1c among
individuals with IDA11 or anemia.12 These differences may relate to
the multiple etiologies for anemia, which include ID, sickle cell
disease or other thalassemias, vitamin B12 deficiency or folate
deficiency.5 ID may be caused by insufficient iron intake, inability
to absorb iron, blood loss, menstrual blood loss or pregnancy.5
With these multiple etiologies, IDA may represent two separate
disease processes, anemia and ID. Furthermore, susceptibility to,
or severity of, ID versus anemia may differ by sex because of
menstruation in women. Few population-based studies have
separated ID and anemia into mutually exclusive categories to
examine how each may differentially impact prediabetes and
diabetes prevalence estimates using HbA1c.
Thus, we examined how anemia alone, ID alone and IDA were
each associated with the prevalence of prediabetes and diabetes
when using FBG and HbA1c in a population-based sample of 7308
Chinese adults aged 18–75 years from the China Health and
Nutrition Survey. We examined the variation in the prevalence of
prediabetes or diabetes using descriptive and covariate-controlled
analyses, hypothesizing that IDA would result in over-diagnosis of
diabetes using HbA1c versus FBG.
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MATERIALS AND METHODS
Study design and participants
The China Health and Nutrition Survey is a longitudinal study across 228
communities within nine provinces of China. Surveys began in 1989, with
subsequent surveys every 2–4 years, for a total of nine rounds between
1989 and 2011. The China Health and Nutrition Survey was designed to
provide representation of rural, urban and suburban areas varying
substantially in geography, economic development, public resources and
health indicators,13 and it is the only large-scale, longitudinal study of its
kind in China. The original survey in 1989 used a multistage, random
cluster design in eight provinces (Liaoning, Jiangsu, Shandong, Henan,
Hubei, Hunan, Guangxi and Guizhou) to select a stratified probability
sample; a ninth province, Heilongjiang, was added in 1997 using a similar
sampling strategy. Essentially, two cities (one large and one small city—
usually the provincial capital and a lower income city) and four counties
(stratified by income: one high, one low and two middle income counties)
were selected in each province. Within cities, two urban and two suburban
communities were selected; within counties, one community in the capital
city and three rural villages were chosen. Twenty households per
community were then selected for participation. The study met the
standards for the ethical treatment of participants and was approved by
the Institutional Review Boards of the University of North Carolina at
Chapel Hill and the Institute of Nutrition and Food Safety, Chinese Center
for Disease Control and Prevention. More detailed survey procedures can
be found elsewhere.13
Adults aged 18–75 years with a blood draw at the 2009 China Health
and Nutrition Survey exam were eligible for inclusion (n= 8102). Of these
8102 adults, individuals were excluded due to: pregnancy at the time of
survey (n= 62), having a nonfasting blood measurement (n=354) or
missing data on one or more measures: HbA1c (n=56), FBG (n= 19),
hemoglobin (n= 32), ferritin (n= 11), transferrin receptor (n= 11), C-reactive
protein (n=1), waist circumference (n= 222), household income (n=101)
or smoking status (men only; n= 30), with some individuals missing
information for more than one variable (total n=378), leaving 7308
individuals in our analytic sample. Of the full eligible sample (n=8102), a
greater proportion of those included (versus excluded) in the analytic
sample (n=7308) were younger, had lower FBG and were from lower
urbanicity areas.
Measures
After an overnight fast, blood was collected by venipuncture (12ml).
Whole blood was immediately centrifuged and serum tested for glucose
using a Hitachi 7600 analyzer using a glucose oxidase phenol
4-aminoantipyrine peroxidase kit (GOD-PAP; Randox, Crumlin, UK). HbA1c
was measured at a central lab in each province with a high-performance
liquid chromatography system (D10 HLC, Bio-Rad, Hercules, CA, USA; PDQ
HPLC, Primus, Kansas City, MO, USA; Model HLC-723 G7, Tosoh
Corporation, Tokyo, Japan). All the samples were calibrated to the D10
HLC from Bio-Rad. Self-report questionnaires were used to ascertain
medical history and current medication use. We compared prevalent
diabetes using HbA1c (HbA1c ⩾ 6.5% (48 mmolmol− 1)) versus FBG (FBG
⩾ 126mg dl− 1 (7.0 mmol l− 1)).1 We considered individuals reporting
diabetes diagnosis (answering ‘yes’ to the question ‘has a doctor ever
told you that you suffer from diabetes?’) and treatment (reporting diabetes
medication use) as having diabetes. For prevalent prediabetes, we used
HbA1c (HbA1c= 5.7–6.5% (39–48mmol mol− 1)) versus FBG (FBG= 100–
126mg dl− 1 (5.5–7.0 mmol l− 1)) according to the American Diabetes
Association guidelines,1 excluding individuals classified with diabetes
according to any criteria (HbA1c, FBG, diabetes diagnosis or diabetes
medication). In descriptive analyses and multinomial logistic regression
models, we categorized individuals according to their diabetes status
(nondiabetic, diabetesFBG (discordant, by FBG only), diabetesHbA1c (dis-
cordant, by HbA1c only) or diabetesHbA1c+FBG (concordant by FBG and
HbA1c)) and prediabetes status (normoglycemia, prediabetesFBG, predia-
betesHbA1c or prediabetesHbA1c+FBG).
Hemoglobin and iron status markers were measured at a national
central lab in Beijing (medical laboratory accreditation certificate ISO 15
189:2007) with strict quality control. From serum, soluble transferrin
receptor was measured via nephelometry on a Siemens BNP (Seimans
China, Beijing, China) and ferritin was measured via radioimmunoassay on
a Gamma counter XH-6020 (North Institute of Bio-Tech, Beijing, China).
From whole blood, hemoglobin was measured via VCS on a Beckman
Coulter LH750 (Beckman, Brea, CA, USA). Because acute infection artificially
raises ferritin, we followed WHO recommendations and multiplied the
measured ferritin values in 802 individuals with a C-reactive protein ⩾
5mg l− 1 by 0.65.14 Anemia alone was defined as hemoglobin o12 g dl− 1
(women) or o13 g dl− 1 (men) according to WHO guidelines5 without ID
(defined as inflammation-adjusted ferritin o15 μg l− 1 or transferrin
receptor ⩾ 1.76mg l− 1 without anemia).5 IDA was defined as having
anemia and ID according to WHO recommendations.15
Age, sex, smoking status and pregnancy status/history were self-
reported at each survey. Household income was derived from individual
and household questionnaires from time-use, asset and economic activity
at each survey and inflated to 2009 Yuan currency in analysis for
comparability over time, and categorized into tertiles. Waist circumference
was measured midway between the lowest rib and the iliac crest using
nonelastic tape. Urbanicity, which reflects the degree of modernization of
each of the China Health and Nutrition Survey communities, was measured
using a multicomponent scale incorporating infrastructure, economic and
social service domains (range: 0–120). The scale has high reliability and
validity,16 with higher urbanicity score corresponding to having more
‘urban’ characteristics across multiple domains. We categorized urbanicity
into tertiles. We controlled for region (North, Central, South) due to
regional differences in geography and diet across China.
Statistical analyses
Descriptive analyses. All analyses were conducted in Stata 13 (Stata Corp,
College Station, TX, USA). First, we examined the differences in sample
characteristics by sex, using χ2 or analysis of variance tests for categorical
or continuous variables, respectively. Second, we examined sex-specific
differences in diabetes classification (nondiabetic, diabetesHbA1c, diabe-
tesFBG or diabetesHbA1c+FBG) or prediabetes classification (normoglycemia,
prediabetesHbA1c, prediabetesFBG or prediabetesHbA1c+FBG) according to ID
and/or anemia status (normal iron/hemoglobin, anemia alone, ID or IDA),
testing group-level differences in the classification via χ2 tests. Third,
among individuals with diabetes or prediabetes, we examined
the mismatch between the prevalence of diabetes and prediabetes
(separately) on the basis of HbA1c versus FBG (concordant by HbA1c and
FBG; discordant by FBG only; discordant by HbA1c only) using pairwise
χ2 tests comparing categories of ID alone, anemia alone or IDA with normal
iron/hemoglobin as referent. Statistical significance was set at the Po0.05
level for all descriptive analyses.
Statistical modeling. We used sex-specific multinomial logistic regression
models to examine the estimated relative risk ratios (RRR) of diabetes using
concordant and discordant classification by HbA1c and FBG (diabetesFBG,
diabetesHbA1c, diabetesHbA1c+FBG and nondiabetic (referent)) across cate-
gories of ID and/or anemia status, controlling for confounding by
demographic, social and environmental factors. An identical set of models
predicted relative risk of concordant and discordant prediabetes
classification using HbA1c and FBG (prediabetesFBG, prediabetesHbA1c,
prediabetesHbA1c+FBG and normoglycemia (referent)), excluding n= 737
individuals with diabetes according to either FBG, HbA1c, doctor diagnosis
or diabetes medication use. We stratified models by sex because cutpoints
for anemia and ID differ by sex and because interaction terms between
categories of ID/anemia status and sex were statistically significant
(Po0.05). Final models included age (linear), urbanicity (low, medium,
high), number of cigarettes smoked per day (linear and quadratic; men
only due to low smoking prevalence (3%) in women), pregnancy history
(ever versus never; women only), household income (low, medium, high),
region (North, Central, South) and waist circumference (linear). Models
were clustered at the community level using a Huber–White type variance
estimator to correct standard errors.17 In figures, we present relative risk
ratios (RRRs) from these models and model-based predicted prevalence of
diabetes or prediabetes using FBG only, HbA1c only or both FBG and
HbA1c across ID/anemia categories.
Sensitivity analysis. Because individuals with the genetic hemoglobin
E (HbE) variant could have an artificially lower HbA1c relative to individuals
without HbE,18 we conducted an additional analysis excluding participants
from the South region (where the HbE trait is most common) to determine
whether relationships among ID, anemia, IDA and diabetes classification by
HbA1c versus FBG were different in the presence of the HbE genetic
variant.
Because provinces of China vary greatly in climate, altitude, and terrain,
potentially affecting biochemical parameters related to hemoglobin and
anemia,19 we conducted two sensitivity analyses: first, we repeated our
analysis stratified by region to see whether the magnitude or direction of
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association differed by region. Second, we redefined our region variable
according to the four regions identified in a paper by Miao, et al.19 to
examine whether our results were sensitive to the classification of region.
Role of the funding source
The sponsors of the study had no role in study design, data collection, data
analysis, data interpretation, writing of the report and the decision to
submit for publication. The corresponding author had full access to all the
data in the study and had final responsibility for the decision to submit for
publication.
RESULTS
Prevalence of prediabetes, diabetes, ID and anemia
Approximately 35% of men and women had HbA1c or FBG above
the prediabetes thresholds. Although 11.1% of men and 9.2% of
women were classified as having diabetes by either FBG, HbA1c,
physician diagnosis or medication use, only 6.2% of men and 4.8%
of women had diabetes using both HbA1c and FBG, physician
diagnosis or medication use (Table 1). The prevalence of ID and/or
anemia was ~ 20% for men and 40% for women.
Differences in prevalence of diabetes by ID and/or anemia status
In unadjusted analyses, there was a statistically significant
difference in diabetes (men: P= 0.04; women: P= 0.008) and
prediabetes (men: Po0.001; women: Po0.001) classification
using FBG versus HbA1c across categories of ID and/or anemia
status (Table 2).
Among individuals with diabetes, fewer individuals with ID
alone (men: 12.9%; women: 19.1%) were estimated to have
diabetes using HbA1c only (diabetesHbA1c) compared with
individuals with normal iron/hemoglobin (men: 25.1%; women:
38.3%; Po0.05; Figure 1). However, among individuals with
prediabetes, more men with anemia alone (66.1%) versus normal
iron/hemoglobin (42.2%; Po0.05) were estimated to have
prediabetesHbA1c. Among individuals with prediabetes, more







Mean or % Standard error Mean or % Standard error
FBG mg dl− 1, mean (s.e.) 97.1 0.5 95 0.4 o0.001
HbA1c %, mean (s.e.) 5.6 0 5.6 0 0.08
Diabetes status,b % (s.e.) o0.001
Nondiabetic 88.9% 0.5% 90.8% 0.5%
DiabetesHbA1c 2.5% 0.3% 3.0% 0.3%
DiabetesFBG 2.4% 0.3% 1.4% 0.2%
DiabetesHbA1c+FBG 6.2% 0.4% 4.8% 0.3%
Prediabetes/diabetes status,c % (s.e.) 0.58
Normoglycemia 64.5% 0.9% 65.5% 0.8%
Prediabetes/diabetesHbA1c 15.9% 0.7% 16.2% 0.6%
Prediabetes/diabetesFBG 12.0% 0.6% 11.0% 0.5%
Prediabetes/diabetesHbA1c+FBG 7.6% 0.5% 7.3% 0.4%
Age, mean (s.e.) 49.0 0.2 49.3 0.2 0.61
Iron/anemia status,d % (s.e.) o0.001
Normal iron and hemoglobin 79.4% 0.7% 60.1% 0.8%
Anemia alone 4.6% 0.4% 8.2% 0.4%
Iron deficiency alone 12.7% 0.6% 22.0% 0.7%
Iron-deficiency anemia 3.2% 0.3% 9.8% 0.5%
Waist circumference cm, mean (s.e.) 84.5 0.2 81.1 0.2 o0.001
Urbanization, % (s.e.)e 0.43
Low 34.4% 0.8% 33.1% 0.8%
Medium 33.7% 0.8% 33.9% 0.8%
High 31.9% 0.8% 33.1% 0.8%
Income, % (s.e.) 0.06
Low 31.3% 0.8% 33.8% 0.8%
Medium 34.5% 0.8% 33.6% 0.8%
High 34.2% 0.8% 32.6% 0.8%
Region, % (s.e.) 0.85
North 21.1% 0.7% 20.6% 0.6%
Central 35.6% 0.8% 36.0% 0.8%
South 43.4% 0.8% 43.4% 0.8%
Abbreviations: FBG, fasting blood glucose; HbA1c, hemoglobin A1c; s.e., standard error. aP-value for χ2 (categorical) or analysis of variance (continuous) test for
difference in sample characteristics by sex. bDiabetes was classified as nondiabetic (FBG o126mg dl−1 and HbA1c o6.5% (48 mmol mol− 1)), diabetesHbA1c
(HbA1c ⩾ 6.5% (48 mmol mol− 1) and FBG o126mg dl−1), diabetesFBG (FBG ⩾ 126 mg dl− 1 and HbA1c o6.5% (48 mmol mol− 1)) or diabetesHbA1c+FBG (FBG
⩾ 126mg dl− 1 and HbA1c ⩾ 6.5% (48 mmol mol− 1), doctor diagnosis or reported diabetes medication use). cPrediabetes/diabetes classified as normal (FBG
o100 mg dl− 1 and HbA1c o5.7% (39 mmol mol− 1)), prediabetes/diabetesHbA1c (HbA1c ⩾ 5.7% (39mmol mol− 1) and FBG o100mg dl− 1), prediabetes/
diabetesFBG (FBG ⩾ 100 mg dl− 1 and HbA1c o5.7% (39 mmol mol− 1)), or prediabetes/diabetesHbA1c+FBG (FBG ⩾ 100mg dl− 1 and HbA1c ⩾ 5.7% (39 -
mmol mol− 1), doctor diagnosis or reported diabetes medication use). dThe four categories of iron and/or anemia status are defined as follows: normal iron and
hemoglobin (hemoglobin ⩾ 12 g dl− 1 (women) or ⩾ 13 g dl− 1 (men), ferritin ⩾ 15 μg l− 1, soluble transferrin receptor o1.76mg l− 1), anemia alone
(hemoglobin o12 g dl− 1 (women) or o13 g dl− 1 (men) without iron deficiency), iron deficiency alone (ferritin o15 μg l−1 or transferrin receptor ⩾ 1.76 -
mg l− 1 without anemia) and iron-deficiency anemia (anemia: hemoglobin o12 g dl−1 (women) or o13 g dl− 1 (men) as well as iron-deficiency: ferritin
o15 μg l− 1 or transferrin receptor ⩾ 1.76 mg l− 1). eColumn percents may not add to 100% due to rounding.
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individuals with IDA (men: 63%; women: 55.2%) versus normal
iron/hemoglobin (men: 42.6%; women: 49.0%) were estimated to
have prediabetesHbA1c.
Using covariate-adjusted models, we examined differences in
the classification of diabetes and prediabetes (separately) using
HbA1c versus FBG across mutually exclusive categories of ID
and/or anemia (Figures 2–4, with RRRs presented in
Supplementary Tables 1 and 2). In comparison with nondiabetic
individuals, women with ID alone versus normal iron/hemoglobin
had lower relative risk of being classified with diabetesHbA1c
(RRR= 0.52; 95% confidence interval (CI): 0.29, 0.95; Figure 2 and
Supplementary Table 1). Similarly, in comparison with diabetesFBG,
women with ID alone versus normal iron/hemoglobin had lower
relative risk of being classified with diabetesHbA1c (RRR = 0.37;
CI: 0.15, 0.88; Figure 2 and Supplementary Table 1). In comparison
with nondiabetic individuals, men with IDA relative to normal
iron/hemoglobin had higher relative risk of being concordantly
classified with diabetesHbA1c+FBG (RRR= 2.38; CI: 1.20, 4.72).
A similar pattern was seen for ID alone relative to normal
iron/hemoglobin (RRR = 1.80; CI: 1.21, 2.67; Figure 2 and
Supplementary Table 1).
From the prediabetes models, relative to normoglycemia, men
with anemia alone versus normal iron/hemoglobin were more
likely to be classified with prediabetesHbA1c (RRR = 1.81; CI: 1.16,
2.82; Figure 3 and Supplementary Table 2). Similarly, in
comparison with prediabetesFBG, men with anemia alone had
higher relative risk of being classified with prediabetesHbA1c
(RRR= 3.00; CI: 1.43, 6.30; Figure 3 and Supplementary Table 2).
Men with ID alone or IDA had higher relative risk of prediabetes
HbA1c than prediabetesHbA1c+FBG. Women with ID alone versus
normal iron/hemoglobin were more likely to be classified with
prediabetesFBG relative to prediabetesHbA1c (RRR = 1.76; CI: 1.25,
2.49). There was relatively little difference in prediabetes by HbA1c
versus FBG for women with IDA.
Using these same covariate-adjusted models, we calculated the
predicted probability of diabetes and prediabetes classification
using FBG only (discordant), HbA1c only (discordant) or both HbA1c
and FBG (concordant; Figure 4). Among women with ID alone, a
smaller percentage were predicted to have diabetesHbA1c (0.5%)
compared with diabetesFBG (1.5%). For men, concordant classifica-
tion of prediabetes (prediabetesHbA1c+FBG) was less common in men
with IDA (1.0%) versus normal iron/hemoglobin (4.0%). A higher
Table 2. Proportion of the sample classified with diabetes and prediabetes by HbA1c only, FBG only, both HbA1c and FBG, or neither according to
categories of iron deficiency and/or anemia status, Chinese adults aged 18–75 years, 2009 China Health and Nutrition Survey




Percent Standard error Percent Standard error Percent Standard error Percent Standard error
Men N= 3027 N= 86 N= 81 N= 211 0.04
Normal iron/hemoglobinc 80.1% 0.7% 81.4% 4.2% 75.3% 4.8% 70.1% 3.2%
Anemia alonec 4.5% 0.4% 5.8% 2.5% 4.9% 2.4% 5.7% 1.6%
Iron deficiency alonec 12.3% 0.6% 9.3% 3.2% 18.5% 4.3% 18.5% 2.7%
Iron-deficiency anemiac 3.1% 0.3% 3.5% 2% 1.2% 1.2% 5.7% 1.6%
Women N= 3542 N= 117 N= 53 N= 189 0.008
Normal iron/hemoglobinc 59.7% 0.8% 75.2% 4% 54.7% 6.9% 59.8% 3.6%
Anemia alonec 7.9% 0.5% 6.8% 2.3% 11.3% 4.4% 12.7% 2.4%
Iron deficiency alonec 22.3% 0.7% 11.1% 2.9% 26.4% 6.1% 21.7% 3%
Iron-deficiency anemiac 10.1% 0.5% 6.8% 2.3% 7.5% 3.7% 5.8% 1.7%




Percent Standard error Percent Standard error Percent Standard error Percent Standard error
Men N= 1952 N= 480 N= 364 N= 231 o0.001
Normal iron/hemoglobinc 78.8% 0.9% 78.8% 1.9% 82.7% 2% 90.5% 1.9%
Anemia alonec 4.1% 0.4% 7.7% 1.2% 2.7% 0.9% 3.9% 1.3%
Iron deficiency alonec 13.7% 0.8% 10.0% 1.4% 12.4% 1.7% 4.8% 1.4%
Iron-deficiency anemiac 3.4% 0.4% 3.5% 0.8% 2.2% 0.8% 0.9% 0.6%
Women N= 2320 N= 572 N= 391 N= 259 o0.001
Normal iron/hemoglobinc 57.6% 1% 66.6% 2% 58.1% 2.5% 65.3% 3%
Anemia alonec 7.9% 0.6% 8.0% 1.1% 9.0% 1.4% 5.8% 1.5%
Iron deficiency alonec 23.5% 0.9% 15.2% 1.5% 25.1% 2.2% 22.8% 2.6%
Iron-deficiency anemiac 10.9% 0.6% 10.1% 1.3% 7.9% 1.4% 6.2% 1.5%
Abbreviations: FBG, fasting blood glucose; HbA1c, hemoglobin A1c. aDiabetes was classified as nondiabetic (FBG o126mg dl− 1 and HbA1c o6.5%
(48 mmol mol− 1)), diabetesHbA1c (HbA1c ⩾ 6.5% (48 mmol mol− 1) and FBG o126mg dl−1), diabetesFBG (FBG ⩾ 126 mg dl− 1 and HbA1c o6.5% (48 -
mmol mol− 1)) or diabetesHbA1c+FBG (FBG ⩾ 126mg dl−1 and HbA1c ⩾ 6.5% (48 mmol mol− 1), doctor diagnosis or reported diabetes medication use).
Prediabetes classification excluded N= 737 individuals with diabetes according to FBG, HbA1c, doctor diagnosis or reported diabetes medication use.
Prediabetes was classified as normoglylcemia (FBG o100 mg dl− 1 and HbA1c o5.7% (39mmol mol− 1)), prediabetesHbA1c (HbA1c= 5.7–6.5% (39–48 -
mmol mol− 1) and FBG o100mg dl− 1), prediabetesFBG (FBG= 100–126 mg dl− 1 and HbA1c o5.7% (39 mmol mol− 1)) or prediabetesHbA1c+FBG (FBG = 100–
126mg dl− 1 and HbA1c= 5.7–6.5% (39–48mmol mol− 1)). Column percents may not add up to 100% due to rounding. bP-value for χ2 test for differences
diabetes or prediabetes classification according to categories of iron deficiency and/or anemia. cIron/anemia status was categorized as normal iron and
hemoglobin (hemoglobin ⩾ 12 g dl− 1 (women) or ⩾ 13 g dl− 1 (men), ferritin ⩾ 15 μg l− 1, soluble transferrin receptor o1.76 mg l−1), anemia alone (as
hemoglobin o12 g dl− 1 (women) or o13 g dl− 1 (men) without iron deficiency), iron deficiency alone (ferritin o15 μg l− 1 or transferrin receptor ⩾ 1.76 -
mg l− 1 without anemia) and iron-deficiency anemia (anemia: hemoglobin o12 g dl− 1 (women) or o13 g dl− 1 (men), as well as iron-deficiency ferritin
o15 μg l− 1 or transferrin receptor ⩾ 1.76 mg l− 1).
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percentage of men with anemia alone were predicted to have
prediabetesHbA1c (22.0%) versus prediabetesFBG (6.8%).
Sensitivity analyses. In our analysis to examine differences in
findings in the presence of the HbE genetic variant, we excluded
participants from the South region (n= 3323) where the HbE
variant is most common. We did not see any differences in the
direction or magnitude of associations between ID, anemia or IDA
(versus normal iron/hemoglobin) with diabetes or prediabetes
classification via HbA1c or FBG, although fewer results were statistically
significant due to the smaller sample size in this subsample.
In our analysis with stratified models by region (North, Central
and South), we did not see differences in the direction or
magnitude of associations, however, estimates were imprecise
due to small sample size.
In our last sensitivity analysis, we redefined our region variable
according to the four regions identified in a paper by Miao, et al.19
to examine whether our results were sensitive to the classification
of region and did not see differences in the direction or
magnitude of associations.
DISCUSSION
ID-related changes in the hemoglobin molecule as well as anemia-
induced erythrocyte turnover differences may result in inaccurate
HbA1c measurements for estimates of diabetes prevalence.
Though HbA1c levels may not accurately reflect glycemia status
if individuals have certain anemias, blood loss or ID, the
magnitude and direction of the associations between ID and/or
anemia with diabetes prevalence using HbA1c has not been
determined. Furthermore, we are aware of no population-based
studies examining differences in the prevalence of prediabetes
and diabetes according to mutually exclusive categories of ID
alone, anemia alone or IDA versus normal iron/hemoglobin. We
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Figure 1. Discordance and concordance in classification of diabetes and prediabetes using HbA1c only, FBG only or with both HbA1c and FBG
by iron/anemia status in Chinese adults aged 18–75 years from the 2009 China Health and Nutrition Survey with diabetes or prediabetes.
Diabetes classified as concordant HbA1c+FBG (FBG ⩾ 126mg dl− 1 and HbA1c ⩾ 6.5% (48mmol mol− 1) or doctor diagnosis), discordant HbA1c
alone (HbA1c ⩾ 6.5% and FBG o126mg dl− 1 (48 mmol mol− 1) with no doctor diagnosis) or discordant FBG alone (FBG ⩾ 126mg dl− 1 and
HbA1c o6.5% (48mmolmol− 1) with no doctor diagnosis). Prediabetes classified as concordant HbA1c+FBG (FBG= 100–126mg dl− 1 and
HbA1c= 5.7–6.5% (39–48mmol mol− 1)), discordant HbA1c alone (HbA1c= 5.7–6.5% (39–48mmol mol− 1) and FBG o100mg dl− 1) or
discordant FBG alone (FBG= 100–126mg dl− 1 and HbA1c o5.7% (39mmolmol− 1)). Iron/anemia status was categorized as normal iron and
hemoglobin (hemoglobin ⩾ 12 g dl− 1 (women) or ⩾ 13 g dl− 1 (men), ferritin ⩾ 15 μg l− 1, soluble transferrin receptor o1.76mg l− 1), anemia
alone (as hemoglobin o12 g dl− 1 (women) or o13 g dl− 1 (men) without iron deficiency), iron deficiency alone (ferritin o15 μg l− 1 or
transferrin receptor ⩾ 1.76mg l− 1 without anemia) and iron-deficiency anemia (anemia: hemoglobin o12 g dl− 1 (women) or o13 g dl− 1
(men), as well as iron-deficiency ferritin o15 μg l− 1 or transferrin receptor ⩾ 1.76 mg l− 1). †Po0.05, denotes statistically significant difference
relative to normal iron/hemoglobin in the percent of individuals classified as concordant FBG and HbA1c, discordant HbA1c only or
discordant FBG only using a chi-squared test. Percents may not add up to 100% due to rounding.
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addressed this gap, finding that fewer women with ID alone
versus normal iron/hemoglobin were predicted to have diabe-
tesHbA1c relative to diabetesFBG, diabetesHbA1c+FBG or as nondia-
betic. Compared with men with normal iron/hemoglobin,
however, more men with anemia alone were predicted to have
prediabetesHbA1c relative to prediabetesFBG, prediabetesHbA1c+FBG
or normoglycemia. The direction of association between IDA and
diabetes/prediabetes using HbA1c versus FBG were mixed across
our statistical models. These findings have important implications
for diabetes prevalence estimates across developing countries
with a high prevalence of both ID and anemia,4 as well as for
developed countries, where HbA1c is often considered preferable
to FBG for glycemia assessment.1
Multiple small, clinic-based studies have examined IDA–HbA1c
relationship, however, inconclusive findings from these studies
may be because ID and anemia represent two different disease
processes. ID, when mild, does not have clinically relevant effects
on hemoglobin levels, whereas severe ID results in concurrent ID
and anemia.5 Though most anemia is due to ID, a large proportion
of anemia cases are due to sickle cell disease or other
thalassemias, vitamin B12 deficiency or folate deficiency.5 Thus,

































































































Figure 2. Multinomial logistic regression models predicting discordance and concordance in classification of diabetes using HbA1c only, FBG
only, or both HbA1c and FBG relative to nondiabetic according to iron deficiency and/or anemia status, from the 2009 China Health and
Nutrition Survey. Diabetes outcome was classified as nondiabetic (FBG o126mg dl− 1 and HbA1c o6.5% (48mmolmol− 1)), HbA1c only
(HbA1c ⩾ 6.5% (48mmol mol− 1) and FBG o126mg dl− 1), FBG only (FBG ⩾ 126mg dl− 1 and HbA1c o6.5% (48mmol mol− 1)) or HbA1c+FBG
(FBG ⩾ 126mg dl− 1 and HbA1c ⩾ 6.5% (48mmol mol− 1), doctor diagnosis of diabetes or reported diabetes medication use). Main exposure
variable was categories of iron deficiency/anemia status. Models were clustered at the community level and adjusted for age, urbanicity level
(low, medium, high), number of cigarettes smoked per day and number of cigarettes squared (men only), ever pregnant (ever versus never;
women only), household income (low, medium, high), region (North, Central, South) and waist circumference. *Po0.05, denotes statistically

































































































Figure 3. Multinomial logistic regression models predicting discordance and concordance in classification of prediabetes using HbA1c only,
FBG only or both HbA1c and FBG relative to normoglycemia according to iron deficiency and/or anemia status, from the 2009 China Health
and Nutrition Survey. Prediabetes model excluded N= 737 individuals with diabetes according to FBG, HbA1c, doctor diagnosis or reported
diabetes medication use. Prediabetes outcome was classified as normal (FBG o100mg dl− 1 and HbA1c o5.7% (39 mmolmol− 1)), HbA1c
only (HbA1c= 5.7–6.5% (39–48mmolmol− 1) and FBG o100mg dl− 1), FBG only (FBG= 100–126mg dl− 1 and HbA1c o5.7% (39 -
mmol mol− 1)) or HbA1c+FBG (FBG= 100–126mg dl− 1 and HbA1c = 5.7–6.5% (39–48mmol mol− 1)). Main exposure variable was categories
of iron deficiency/anemia status. Models were clustered at the community level and adjusted for age, urbanicity level (low, medium, high),
number of cigarettes smoked per day and number of cigarettes squared (men only), ever pregnant (ever versus never; women only),
household income (low, medium, high), region (North, Central, South) and waist circumference. *Po0.05, denotes statistically significant
difference in the relative risk ratios using chi-squared tests. FBG, fasting blood glucose; IDA, iron-deficiency anemia; RRR, relative risk ratio.
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heterogeneous disease processes underlying the relationship
between IDA and HbA1c. For example, ID may artificially increase
HbA1c by inducing changes to the shape of the hemoglobin
molecule, promoting glycation of the terminal valine8 or by
lowering erythrocyte turnover, allowing more time for glycation of
hemoglobin to occur.6,7 Some anemias, on the other hand, may
artificially lower HbA1c because of increased erythrocyte
turnover.20 We know of no population-based studies to date
that have addressed these potentially different mechanisms
by using two separate measures of glycemia status and
mutually exclusive categories of ID alone, anemia alone, IDA or
normal iron/hemoglobin.
We found that in our sample, the prevalence of anemia was
7.8% for men and 18.0% for women, which is comparable to
national representative data from China.21 This prevalence is
similar to the prevalence of anemia in Mexico and is much lower
than the prevalence for India (~50% for women of reproductive
age), but is much higher than the prevalence of anemia in the
United States (~7% for women of reproductive age).4 Previous
studies in China suggest that ID in China may be endemic due to
the fact that the majority of the iron consumed in the Chinese diet
is from plants, a source of non-heme iron of lower biologic
availability compared with animal-source foods.22 The higher
observed prevalence of ID in women versus men suggests that
menstrual blood loss and pregnancy history may be a large
contributor to ID in this population. We also found that ~ 50% of
individuals with anemia had concurrent ID, similar to proportions
observed in many populations.5 It is possible that the other 50% of
individuals with anemia could result from genetic hemoglobino-
pathies, thalassemias or other vitamin deficiencies.
From our multivariable model results, anemia alone and IDA
were associated with greater relative risk of prediabetesHbA1c
versus normoglycemia in men but not women. A previous
population-based study from the US found that among individuals
without diabetes, those with anemia versus normal iron/hemo-
globin had higher mean HbA1c.23 Another found a nonstatistically
significant increase in mean HbA1c among individuals with
anemia.9 However, studies using clinic-based samples from
developing countries have shown lower mean HbA1c in






































































Figure 4. Multinomial logistic regression model-predicted percent of individuals classified with diabetes or prediabetes using HbA1c only, FBG
only or both HbA1c and FBG according to iron deficiency and/or anemia status, from the 2009 China Health and Nutrition Survey. Diabetes
outcome was classified as nondiabetic (FBG o126mg dl− 1 and HbA1c o6.5% (48mmol mol− 1)), HbA1c only (HbA1c ⩾ 6.5% (48 -
mmol mol− 1) and FBG o126mg dl− 1), FBG only (FBG ⩾ 126mg dl− 1 and HbA1c o6.5% (48mmol mol− 1)) or HbA1c+FBG (FBG ⩾ 126 -
mg dl− 1 and HbA1c ⩾ 6.5% (48mmol mol− 1), doctor diagnosis of diabetes or reported diabetes medication use). Prediabetes model excluded
N= 737 individuals with diabetes according to FBG, HbA1c, doctor diagnosis or reported diabetes medication use. Prediabetes outcome was
classified as normoglycemia (FBG o100mg dl− 1 and HbA1c o5.7% (39mmol mol− 1)), HbA1c only (HbA1c= 5.7–6.5% (39–48mmol mol− 1)
and FBG o100mg dl− 1), FBG only (FBG= 100–126mg dl− 1 and HbA1c o5.7% (39 mmolmol− 1)) or HbA1c+FBG (FBG= 100–126mg dl− 1 and
HbA1c = 5.7–6.5% (39–48mmolmol− 1)). Main exposure variable was categories of iron deficiency/anemia status. Models were clustered at the
community level and adjusted for age, urbanicity level (low, medium, high), number of cigarettes smoked per day and number of cigarettes
squared (men only), ever pregnant (ever versus never; women only), household income (low, medium, high), region (north, central, south) and
waist circumference. Patterns of statistical significance can be found in Figures 2 and 3. ID, iron deficiency; IDA, iron-deficiency anemia.
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hemoglobin. These study findings may differ because they were
based in regional, small or clinic-based samples. Sex-based
differences in our study may be due to the lower prevalence of
anemia alone than ID alone in women.
In our sample, we observed that women with ID alone had
lower relative risk of being classified with diabetesHbA1c versus as
nondiabetic. Similar, although nonsignificant, relationships were
seen in men, perhaps owing to sex-based differences in the
prevalence and severity of ID and anemia. Our finding confirms
results from a clinic-based sample of Indian women, which found
lower HbA1c in women with ID versus normal iron,11 but
contradict findings from a population-based study of US adults,
which observed a positive association between ID and HbA1c.9
With the exception of our model predicting prediabetes in
women, the relationship of IDA (versus normal iron/hemoglobin)
with diabetesHbA1c or prediabetesHbA1c (versus normoglycemia),
though not statistically significant, was in the same direction as
the associations we observed between anemia alone and a higher
relative risk of diabetes/prediabetes. It is possible that a positive
relationship between IDA (which is severe ID with anemia) and
HbA1c is attenuated because ID is negatively associated with
HbA1c, while anemia is positively associated with HbA1c. Another
possibility is that the low prevalence of diabetes and IDA,
particularly in men, could have resulted in insufficient statistical
power, or that hemoglobinopathies, thalassemias or other
confounding factors could have reduced the precision of our
estimates. However, our findings suggest that a different direction
of association between ID and HbA1c (negative) versus that
between anemia and HbA1c (positive) may underlie inconsistent
findings in the epidemiologic literature and support the need to
examine both iron and anemia status when assessing diabetes
using HbA1c.
Our study contributes to the literature on influences of
nonglycemic factors on HbA1c, but there are some limitations of
note. In our population-based sample, we do not have an oral
glucose tolerance test, the gold standard of glycemic
measurement1 yet we do have HbA1c and FGB, whereas most
studies only collect one or the other. As a nonclinical study, we
only have one FBG and HbA1c measurement from participants,
which is standard for research studies in the field,24 whereas a
clinical diagnostic test would include replicate measures. We do
not have information on genetic hemoglobinopathies such as
HbE, which affects ~ 30% of Southeast Asians and may artificially
lower HbA1c.18 However, in sensitivity analysis, we excluded
participants from the South region of China where the HbE variant
is most prevalent, and observed similar findings in the full sample,
although estimates were less precise due to the smaller sample
size. Our analysis does not address pregnancy, a time when
women are at high risk of developing ID and gestational diabetes.
However, our study has the great strengths of reporting
population-level associations between ID alone, anemia alone
and IDA and diabetes/prediabetes classification in a population-
based sample, using a standardized and calibrated technique for
HbA1c measurement, allowing us to compare HbA1c across a
large and geographically diverse sample; discordant samples and
techniques would make this impossible.
Using these unique data, we report the impact of anemia alone,
ID or IDA on diabetes and prediabetes prevalence estimates in a
sex-stratified, population-based sample of Chinese adults with
substantial variability in iron, hemoglobin and diabetes measures.
Our findings suggest that ID may result in under-diagnosis of
diabetes and anemia may result in over-diagnosis of diabetes
when using HbA1c. Furthermore, differences in diabetes/predia-
betes classification for individuals with IDA may be driven by the
positive association between anemia and HbA1c, but attenuated
by the opposing, negative association between ID and HbA1c. Our
findings suggest that inconsistent findings in the literature could
be due to the complex disease etiology of IDA, and confirm
warnings that HbA1c should only be used for glycemic assess-
ment in the absence of ID and/or anemia. These findings suggest
that concurrent measurement of iron, hemoglobin and HbA1c is
critical to correctly interpret glycaemia status in populations with
prevalent ID and/or anemia.
CONFLICT OF INTEREST
The authors declare no conflict of interest.
ACKNOWLEDGEMENTS
This work was supported by NIH: the NIH Heart, Lung and Blood Institute (R01-
HL108427). This research uses data from the China Health and Nutrition Survey,
funded by NIH: The Eunice Kennedy Shriver National Institute of Child Health and
Human Development (NICHD; R01-HD30880), though no direct support was received
from grant for this analysis. SMA is supported by the American Heart Association
(14PRE20380362). ALT is supported by NIH: NICHD (K01 HD071948–01). We are
grateful to the Carolina Population Center, University of North Carolina at Chapel Hill,
for general support (grant R24 HD050924 from the NICHD). NIH had no role in the
design and conduct of the study; collection, management, analysis and interpretation
of the data; and preparation, review or approval of the manuscript. SMA and PG-L are
the guarantors of this work and, as such, had full access to all the data in the study
and take responsibility for the integrity of the data and the accuracy of the data
analysis.
AUTHOR CONTRIBUTIONS
HW contributed to the collection of the data. SMA, PG-L, EJM-D, LSA and ALT
contributed to the initial design of the analysis. SMA, AHH, A-GH and PG-L
contributed to the analysis. All authors contributed to the interpretation of data
analysis. SMA and PG-L wrote the first draft of the manuscript. All the authors
revised/edited the manuscript.
REFERENCES
1 American Diabetes Association. Diagnosis and classification of diabetes mellitus.
Diabetes Care 2013; 36: S67–S74.
2 Bonora E, Tuomilehto J. The pros and cons of diagnosing diabetes with A1C.
Diabetes Care 2011; 34 (Suppl 2): S184–S190.
3 Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES, Geiss LS et al. Prevalence of
diabetes and high risk for diabetes using A1C criteria in the U.S. population in
1988-2006. Diabetes Care 2010; 33: 562–568.
4 World Health Organization. Worldwide Prevalence of Anaemia 1993-2005: WHO
Global Database on Anaemia 2008.
5 World Health Organization. Iron Deficiency Anaemia: Assessment, Prevention, and
Control. A guide for Programme Managers 2001.
6 Ahmad J, Rafat D. HbA1c and iron deficiency: a review. Diabetes Metab Syndr
2013; 7: 118–122.
7 Hardikar PS, Joshi SM, Bhat DS, Raut DA, Katre PA, Lubree HG et al. Spuriously high
prevalence of prediabetes diagnosed by HbA1c in young Indians partly explained by
hematological factors and iron deficiency anemia. Diabetes Care 2012; 35: 797–802.
8 Gould B, Davie SJ, Yudkin JS. Investigation of the mechanism underlying the
variability of glycated haemoglobin in non-diabetic subjects not related to gly-
caemia. Clin Chim Acta 1997; 260: 49–64.
9 Kim C, Bullard KM, Herman WH, Beckles GL. Association between iron deficiency
and A1c levels among adults without diabetes in the National Health and
Nutrition Examination Survey, 1999-2006. Diabetes Care 2010; 33: 780–785.
10 Shanthi B, Revathy C, Manjula Devi AJ, Subhashree. Effect of iron deficiency on
glycation of haemoglobin in nondiabetics. J Clin Diagn Res 2013; 7: 15–17.
11 Sinha N, Mishra TK, Singh T, Gupta N. Effect of iron deficiency anemia on
hemoglobin A1c levels. Ann Lab Med 2012; 32: 17–22.
12 Koga M, Morita S, Saito H, Mukai M, Kasayama S. Association of erythrocyte
indices with glycated haemoglobin in pre-menopausal women. Diabet Med 2007;
24: 843–847.
13 Popkin BM, Du S, Zhai F, Zhang B. Cohort Profile: The China Health and Nutrition
Survey--monitoring and understanding socio-economic and health change in
China, 1989-2011. Int J Epidemiol 2010; 39: 1435–1440.
14 Thurnham DI, McCabe GP. Influence of infection and inflammation on biomarkers of
nutritional status with an emphasis on vitamin A and iron. World Health Organi-
zation: Geneva, Switzerland, 2012.
15 World Health Organization and Centers for Disease Control Assessing the iron
status of populations: report of a joint WHO/CDC technical consultation on the
Iron-deficiency anemia and diabetes
SM Attard et al
8
Nutrition & Diabetes (2015) 1 – 9
assessment of iron status at the population level, 2nd edition. World Health
Organization/Centers for Disease Control: Geneva, Switzerland, 2004.
16 Jones-Smith JC, Popkin BM. Understanding community context and adult health
changes in China: development of an urbanicity scale. Soc Sci Med 2010; 71:
1436–1446.
17 Williams RL. A note on robust variance estimation for cluster-correlated data.
Biometrics 2000; 56: 645–646.
18 Little RR, Rohlfing CL, Hanson S, Connolly S, Higgins T, Weykamp CW et al. Effects
of hemoglobin (Hb) E and HbD traits on measurements of glycated Hb (HbA1c) by
23 methods. Clin Chem 2008; 54: 1277–1282.
19 Miao G, Zhang Y, He J, Yan Y, Wang X, Cao L et al. Normal reference value of red
blood cell count of Chinese young men and geographical factors. Semin Diagn
Pathol 2009; 26: 53–60.
20 Gallagher EJ, Le Roith D, Bloomgarden Z. Review of hemoglobin A1c in the
management of diabetes. J Diabetes 2009; 1: 9–17.
21 World Health Organization Vitamin and Mineral Nutrition Information System
(VMNIS). World Health Organization: Geneva, Switzerland, 2006.
22 Du S, Zhai F, Wang Y, Popkin BM. Current methods for estimating dietary iron
bioavailability do not work in China. J Nutr 2000; 130: 193–198.
23 Ford ES, Cowie CC, Li C, Handelsman Y, Bloomgarden ZT. Iron-deficiency anemia, non-
iron-deficiency anemia and HbA1c among adults in the US. J Diabetes 2011; 3: 67–73.
24 Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ et al. National,
regional, and global trends in fasting plasma glucose and diabetes prevalence
since 1980: systematic analysis of health examination surveys and epidemiolo-
gical studies with 370 country-years and 2·7 million participants. Lancet 2011;
378: 31–40.
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated
otherwise in the credit line; if the material is not included under the Creative Commons
license, users will need to obtain permission from the license holder to reproduce the
material. To view a copy of this license, visit http://creativecommons.org/licenses/
by/4.0/
Supplementary Information accompanies this paper on the Nutrition & Diabetes website (http://www.nature.com/nutd)
Iron-deficiency anemia and diabetes
SM Attard et al
9
Nutrition & Diabetes (2015) 1 – 9
